Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "Ibrutinib"

IMBRUVICA (ibrutinib) ya está aprobado en Europa para el trat...

SCHAFFHAUSEN, Suiza, 20 de octubre de 2014 /PRNewswire/ --Pharmacyclics Switzerland GmbH, una filial de Pharmacyclics, Inc. (NASDAQ: PCYC ), ha anunciado hoy que la Comisión Europea (CE) ha concedido una autorización de marketing para IMBRUVICA ... PR Newswire, 1 month ago

3 images for "Ibrutinib"

OncLive, 1 month ago
OncLive, 1 month ago
British Journal of Haematology, 1 month ago

Health Canada approves IMBRUVICA for chronic lymphocytic leukemia

Janssen Inc. has announced Health Canada has approved IMBRUVICA (ibrutinib) for the treatment of the blood cancer chronic lymphocytic leukemia (CLL). It is indicated for the treatment of patients with CLL, including those with 17p deletion, who have ...
 Medical News Today2 days ago Pharmacyclics Inc announces IMBRUVICA (ibrutinib) approved in Europe for treatment of two blood cancers  Reuters1 month ago Health Canada Approves IMBRUVICA by Priority Review, Giving Physicians and Patients a Much-Needed Option in the Fight Against Chronic Lymphocytic Leukemia  Canada NewsWire3 days ago Health Canada Approves IMBRUVICA(TM) by Priority Review, Giving Physicians and Patients a Much-Needed Option in the Fight Against Chronic Lymphocytic Leukemia  Canada NewsWire3 days ago
Bioresearch Online

IMBRUVICA® (ibrutinib) Data to be Presented Across Multiple Histologies, Including in Eight Oral Presentations, at 2014 American Society of Hematology (ASH) Annual Meeting

News Story Sorry, the story you were looking for is not available. Back to News Tweet Radar -ALLSYMB- AIG GOOG Scroll over any stock symbol to predict whether that stock's value will go up or down and to view other valuable ...
 PredictWallStreet2 weeks ago IMBRUVICA ibrutinib Supplemental New Drug Application Submitted to the U.S. FDA for Waldenstrom's macroglobulinemia  Pharmacy Choice2 weeks ago AstraZeneca And Pharmacyclics Enter Immuno-Oncology Clinical Trial Collaboration With IMBRUVICA® In Solid Tumors  ADVFN UK2 weeks ago TG Therapeutics, Inc. Announces Data Presentations at the Upcoming 56th American Society of Hematology Annual Meeting  Morningstar.com2 weeks ago

New Chronic Lymphocytic Leukemia Findings Has Been Reported by Investigators at Pharmacyclics Inc. (Ibrutinib inhibits BCR and NF-kappa B signaling...

New Chronic Lymphocytic Leukemia Findings Has Been Reported by Investigators at Pharmacyclics Inc. (Ibrutinib inhibits BCR and NF-kappa B signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL) By a News ...
 4 Traders3 weeks ago Data from Pharmacyclics Inc. Advance Knowledge in Chronic Lymphocytic Leukemia (Kinetics of CLL cells in tissues and blood during therapy with the...  4 Traders3 weeks ago
FDA News

European Commission approves ibrutinib in two forms of blood cancer

Janssen-Cilag International NV (Janssen) has announced that the European Commission has approved ibrutinib (imbruvica)capsules, a first-in-class, once-daily, oral Bruton's tyrosine kinase (BTK) inhibitor. This new approach to treating blood ...
 Ecancer Medicalscience1 month ago EMA Approves Blood Cancer Drug Imbruvica for Two Indications  FDA News4 weeks ago
Seeking Alpha

Johnson & Johnson's Partnership With Geron Emphasizes Its Push In Oncology

Johnson & Johnson (NYSE:JNJ) has entered a partnership with Geron to develop its blood cancer treatment candidate, Imetelstat. The news sent the shares of Geron up by 40%, which means that for Geron's investors this is a big deal. As far as J&J is ...
 Trefis3 days ago Johnson & Johnson: Still A Solid Dividend Growth Pick  Seeking Alpha2 weeks ago
Pharma Letter

Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight

The market for Non Hodgkin Lymphoma has significant unmet medical necessities in terms of demand for innovative drugs and novel technologies. This is one of the major factors behind the market witnessing rapid growth in Non Hodgkin Lymphoma segment.
 Global Information Inc2 days ago Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options  Minyanville1 week ago The Report Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting  Digital Journal1 week ago Non-Hodgkin lymphoma market to grow to $9.2 billion  Pharma Letter3 weeks ago

Global drug tab will breach trillion dollar mark this year

According to IMS Health (NYSE:IMS) global drug spending will top $1T this year led by Gilead's (NASDAQ:GILD) Sovaldi (sofosbuvir) for hep C and new cancer drugs. The projected spend of $1.06T represents a 7% increase from last year. By 2018, drug ...
 Seeking Alpha2 days ago

Global drug spending set to top $1 trillion

Kadcyla (ado-trastuzumab emtansine) is among the drugs driving high prices Worldwide spending on drugs will reach over $1 trillion in 2014 and $1.3 trillion by 2018, according to a new report. The study by the IMS Institute for Healthcare ...
 Pharmafocus2 days ago

Biotech Watchlist Update: Small-Cap Biotechs Struggle to Rebound

When the biotechnology market hit a speed bump in early 2014, every stock in the sector was jolted. Large-cap biotech and big pharma have largely recovered, but small- and micro-cap companies haven't yet entirely recouped the losses. The ...
 BioMedReports3 days ago What's Done Better for Investors: Small Biotechs or Big Pharma?  Equities.com1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less